ASX - By Stock
|
BOT |
Re:
SOFDRA market size
|
|
Moreforme
|
43 |
12K |
7 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
43
|
12K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Moreforme
|
510 |
148K |
8 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
510
|
148K
|
8
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Artificial Intelligence Platform Update
|
|
Moreforme
|
18 |
5.5K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
18
|
5.5K
|
0
|
|
ASX - By Stock
|
SOL |
Re:
Waiting for sub $30 entry
|
|
Moreforme
|
7 |
4.1K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
7
|
4.1K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Moreforme
|
77 |
17K |
17 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
77
|
17K
|
17
|
|
ASX - By Stock
|
LKO |
Re:
General Conversation
|
|
Moreforme
|
1.1K |
519K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
1.1K
|
519K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
23 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
971
|
226K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Moreforme
|
58 |
14K |
4 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
58
|
14K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Moreforme
|
58 |
14K |
9 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
58
|
14K
|
9
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
Moreforme
|
7.7K |
2.8M |
14 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
7.7K
|
2.8M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
Moreforme
|
510 |
148K |
9 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
510
|
148K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Moreforme
|
77 |
17K |
11 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
77
|
17K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
10 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
971
|
226K
|
10
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
Moreforme
|
164 |
42K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
42K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
1AI super thread
|
|
Moreforme
|
32 |
15K |
4 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
32
|
15K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
7 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
971
|
226K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
Moreforme
|
86 |
32K |
3 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
86
|
32K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
Moreforme
|
166 |
77K |
17 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
166
|
77K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
Moreforme
|
166 |
77K |
7 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
166
|
77K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
Moreforme
|
86 |
32K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
86
|
32K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Moreforme
|
304 |
71K |
17 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
304
|
71K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
X
|
|
Moreforme
|
9 |
2.2K |
8 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
9
|
2.2K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Moreforme
|
152 |
42K |
21 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
42K
|
21
|
|
ASX - By Stock
|
PAA |
Company Value Maximisation
|
|
Moreforme
|
0 |
282 |
10 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
0
|
282
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Moreforme
|
152 |
42K |
8 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
42K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
Moreforme
|
111 |
33K |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
111
|
33K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Moreforme
|
152 |
42K |
29 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
42K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
M C anyone ?
|
|
Moreforme
|
11 |
3.3K |
12 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
11
|
3.3K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Moreforme
|
114 |
30K |
11 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
30K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Moreforme
|
114 |
30K |
11 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
30K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Moreforme
|
323 |
71K |
14 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
323
|
71K
|
14
|
|
ASX - By Stock
|
WOW |
Re:
Four Corners - Supermarket Power
|
|
Moreforme
|
59 |
14K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
59
|
14K
|
1
|
|
ASX - By Stock
|
GLL |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Moreforme
|
18 |
4.1K |
1 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
18
|
4.1K
|
1
|
|
ASX - By Stock
|
WOW |
Re:
News: WOW Australia's Woolworths Group CEO Brad Banducci to retire
|
|
Moreforme
|
87 |
21K |
6 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
87
|
21K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Moreforme
|
17K |
6.5M |
20 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
17K
|
6.5M
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
6 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
971
|
226K
|
6
|
|
ASX - By Stock
|
ANZ |
Re:
Ann: ANZ welcomes Australian Competition Tribunal decision
|
|
Moreforme
|
14 |
5.8K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
14
|
5.8K
|
2
|
|
ASX - By Stock
|
SUN |
Re:
Ann: Suncorp Welcomes Tribunal Decision on Suncorp Bank Sale
|
|
Moreforme
|
7 |
3.0K |
0 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
7
|
3.0K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
16 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
971
|
226K
|
16
|
|
ASX - By Stock
|
WOW |
Re:
Sack the CEO!
|
|
Moreforme
|
193 |
38K |
5 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
193
|
38K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
14 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
971
|
226K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
19 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
971
|
226K
|
19
|
|
Political Debate
|
|
Re:
Assylum seeker boat arrives WA
|
|
Moreforme
|
40 |
4.8K |
7 |
17/02/24 |
17/02/24 |
Political Debate
|
40
|
4.8K
|
7
|
|
Breaking News
|
|
You're going to foot the bill...Sucker...Again!
|
|
Moreforme
|
15 |
1.8K |
4 |
16/02/24 |
16/02/24 |
Breaking News
|
15
|
1.8K
|
4
|
|
ASX - By Stock
|
WOW |
Re:
Sack the CEO!
|
|
Moreforme
|
193 |
38K |
2 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
193
|
38K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
Moreforme
|
238 |
79K |
2 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
238
|
79K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Moreforme
|
971 |
226K |
5 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
971
|
226K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Revascor
|
|
Moreforme
|
38 |
14K |
27 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
38
|
14K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Revascor
|
|
Moreforme
|
38 |
14K |
23 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
38
|
14K
|
23
|
|
ASX - By Stock
|
WOW |
Re:
Sack the CEO!
|
|
Moreforme
|
193 |
38K |
3 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
193
|
38K
|
3
|
|